Repligen | RGEN - 资产

股票价格
123.46
每天变化
-2.97 -2.35%
每月一次
3.07%
每年
0.18%
Q2 预测
114.76


金融业
股票价格
USD
资产
USD 2.93B
现金及等价物
USD 582.65M
销售成本
USD 85.97M
流动资产
USD 1.16B
流动负债
USD 126.21M
债务
USD 546.59M
EBIT
USD 19.98M
EBITDA
USD 40.01M
员工
1.78K
EPS每股收益
USD 0.48
股本和储备
USD 2.11B
销售毛利
USD 108.28M
债务利息支出
USD 5.58M
利息收入
USD 7.31M
贷款资金
USD 546.59M
市值
USD 7.05B
净收入
USD 8.33M
营业费用
USD 174.27M
营业利润
USD 19.98M
普通股股本
USD 56.4M
PE价格收益
109.48
税前利润
USD 19.11M
销售收入
USD 194M
销售和管理费用
USD 76.54M
股票
USD 179.26M
贸易债权人
USD 34.66M
应收帐款人
USD 151.55M


资产 更改 日
Agilent USD 12.81B 86M 2025-12
Align Technology USD 6.31B 80.48M 2026-03
Bio Techne USD 2.55B 27.9M 2026-03
BioMarin Pharmaceutical USD 8.59B 996.99M 2026-03
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Bruker USD 6.13B 110.7M 2026-03
Charles River Laboratories USD 7.73B 594.89M 2026-03
Danaher USD 83.54B 80M 2026-03
Dentsply International USD 5.23B 200M 2026-03
General Electric Aerospace USD 128.45B 1.72B 2026-03
Henry Schein USD 11.3B 89M 2026-03
Illumina USD 6.56B 85M 2026-03
IQVIA Holdings USD 29.68B 269M 2026-03
Mettler Toledo International USD 3.67B 43.73M 2026-03
Myriad Genetics USD 673.7M 32.9M 2026-03
OraSure Technologies USD 379.17M 24M 2026-03
Pacific Biosciences Of California USD 784.08M 19.08M 2025-12
Pfizer USD 207.62B 542M 2026-03
Repligen USD 2.93B 18.93M 2026-03
Revvity USD 12B 171.82M 2026-03
Standard Biotools USD 639.11M 71.36M 2026-03
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03
Waters USD 24.53B 19.45B 2026-03
West Pharmaceutical Services USD 4.11B 160.2M 2026-03